Savara announces new leadership appointments

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the appointments of two pharmaceutical industry veterans to its executive leadership team. rob lutz has been appointed chief operating officer, effectively immediately.

SVRA Ratings Summary

SVRA Quant Ranking